ARGENX SE

ARGX
Real-time Quote. Real-time  - 06/24 11:38:54 am
266.6EUR +2.38%

Turn to zoom
Prev.260.4000
Open261.1000
High268.4000
Low259.5000
Volume69 105
Latest news
6d ago
7d ago
7d ago
06/16
Chart ARGENX SE
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance268312310
Spread/Res.-0,34%-15%-14%
Spread/Supp.11%28%46%
Support240209183
Financials
Sales 2021 172 M 205 M 205 M
Net income 2021 -589 M -703 M -703 M
Net cash 2021 1 595 M 1 903 M 1 903 M
P/E ratio 2021 -25,2x
Yield 2021 -
Capitalization 13 678 M 16 316 M 16 318 M
EV / Sales 2021 70,4x
EV / Sales 2022 66,8x
Nbr of Employees 336
Free-Float 99,0%
Company
argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-07-29 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 266,60 €
Average target price 262,89 €
Spread / Average Target -1,39%